Differential EGF action on nuclear protooncogenes in human endometrial carcinoma RL95-2 cells

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 401-406

  Sallot, Myriam ^a   Ordener, Catherine ^a   Lascombe, Isabelle ^a   Propper, Alain ^a   Adessi, Gerard L ^a   Jouvenot, Michele ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Cancer; Cell proliferation; Endometrium; Epidermal growth factor; Protooncogene

Indexed keywords

EPIDERMAL GROWTH FACTOR; MESSENGER RNA;

ARTICLE; CANCER INHIBITION; CELL COUNT; CONTROLLED STUDY; CULTURE MEDIUM; ENDOMETRIUM CARCINOMA; FETAL CALF SERUM; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE C FOS; ONCOGENE C JUN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE;

CELL CYCLE; CELL DIVISION; CELL NUCLEUS; ENDOMETRIAL NEOPLASMS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION; GENES, FOS; GENES, JUN; GENES, MYC; HUMANS; PROTO-ONCOGENES; TUMOR CELLS, CULTURED;

EID: 0029872348     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Herschman HR: Primary response genes induced by growth factors and tumor promoters: Annu Rev Biochem 60: 281-319, 1991.
2. Cicatiello L, Sica V, Bresciani F and Weisz A: Identification of a specific pattern of "immediate-early" gene activation induced by estrogen during mitogenic stimulation of rat uterine cells. Receptor 3: 17-30, 1993.
3. Bishop MJ: The molecular genetics of cancer. Science 235: 305-311, 1987.
4. Lin TH, Mukku VR, Verner G, Kirkland JL and Stancel GM: Autoradiographic localization of epidermal growth factor receptors to all major uterine cell types. Biol Reprod 38, 403-411, 1988.
5. Goeppinger A, Wittmaack FM, Wintzner HO, Ikenberg H and Bauknecht T: Localization of human epidermal growth factor receptor in cervical intraepithelial neoplasias. J Cancer Res Clin Oncol 115: 259-263, 1989.
6. Bauknecht T, Kohler M, Janz I and Pfleiderer A: The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. J Cancer Res Clin Oncol 115: 193-199, 1989.
7. Lelle RJ, Talavera F, Gretz H, Roberts JA and Menon KMJ: Epidermal growth factor receptor expression in three different human endometrial cancer cell lines. Cancer 72: 519-525, 1993.
8. Tomooka Y, DiAugustine RP and McLachlan JA: Proliferation of mouse uterine epithelial cells in vitro. Endocrinology 118: 1011-1018, 1986.
9. Way DL, Grosso DS, Davis JR, Surwit EA and Christian CD: Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro 19: 147-158, 1983.
10. Korc M, Padilla J and Grosso D: Epidermal growth factor inhibits the proliferation of human endometrial carcinoma cell line. J Endocrinol Metab 62: 874-880, 1986.
11. Korc M, Haussler CA and Trookman NS: Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. Cancer Res 47: 4909-4914, 1987.
12. Melli M, Spinelli G and Arnold E: Synthesis of histone messenger RNA of Hela cells during the cell cycle. Cell 12: 167-174, 1977.
13. Ordener C, Cypriani B, Vuillermoz C and Adessi GL: Epidermal growth factor and insulin induce the proliferation of guinea-pig endometrial stromal cells in serum-free culture, whereas estradiol and progesterone do not. Biol Reprod 49. 1032-1044, 1993.
14. Chomczynski P and Sacchi N: Single step method of RNA isolation by acid guanidium. Anal Biochem 162: 156-159, 1987.
15. Thomas PS: Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77: 5201-5205, 1980.
16. Pardee AB: A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 71: 1286-1290, 1974.
17. Ashihara T and Baserga R: Cell synchronization. In: Methods in Enzymology: Cell Culture (Jakoby WB and Pastan IH, eds). NewYork, Academic Press Inc, 1979, Vol. 58, pp. 248-262.
18. Aitken S.C, Lippman ME, Kasid A and Schoenberg DR: Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells. Cancer Res 45: 2608-2615, 1985.
19. Curran T and Franza R: Fos and Jun: the AP-1 connection. Cell 55: 395-397, 1988.
20. Curran T: Fos and Jun: oncogenic transcription factors. J Exp Med 168: 169-174, 1992.
21. Liu Y and Teng CT: Identification of the estrogen sensitive marker in human endometrial carcinoma RL95-2 cells. Mol Cell Endocrinol 101: 167171, 1994.
22. Kelly K, Cochran BH, Stiles C and Leder P: Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35: 603-610, 1983.
23. Hoffman B and Liebermann DA: Molecular controls of apoptosis: differentiation/growth arrest primary response genes, protooncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene 9: 1807-1812, 1994.
24. Okuda A, Matsuzaki A and Kimura G: Transient increase in the c-fos mRNA level after change of culture condition from serum absence to serum presence and after cycloheximide addition in rat 3Y1 fibroblasts. Biochem Biophys Res Commun 159: 501-507, 1989.
25. Rabbitts PH, Watson JV, Lamond A, Forster A, Stinson MA, Evan GI, Fischer W, Atherton E, Sheppard R and Rabbitts TH: Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J 4: 2009-2015, 1985.
26. Sinha S, Neal GE, Legg RF, Watson JV and Pearson C: The expression of c-myc related to the proliferation and transformation of rat liver-derived epithelial cells. Br J Cancer 59: 674-676, 1989.
27. Liboi F., Pclosi E, Testa U, Peschle C and Rossi GB: Proliferative response and oncogene expression induced by epidermal growth factor in EL2 rat fibroblasts. Mol Cell Biol 6: 2275-2278, 1986
28. Liu E, Santos G, Lee WMF, Osborne CK and Benz CC: Effects of c-myc overexpression on the growth characteristics of MCF-7 human breast cancer cells. Oncogene 4: 979-984, 1989.